ASCO Genitourinary Cancers Symposium
ASCO GU 2022 on Futibatinib + Pembro in Advanced/Metastatic UC: Preliminary Safety Results From a Phase 2 Study
By
ASCO Genitourinary Cancers Symposium
FEATURING
Vadim Koshkin
By
ASCO Genitourinary Cancers Symposium
FEATURING
Vadim Koshkin
Login to view comments.
Click here to Login